A year later, RFK Jr.'s plan for vaccine safety commission seems stalled

The Trump Administration has backed away from plans to set up a vaccine safety commission, RFK Jr. said. (Pixabay)

Before assuming office last year, then-President-elect Donald Trump took a controversial meeting with vaccine skeptic Robert Kennedy Jr. to discuss a commission to investigate vaccine safety, Kennedy told reporters at the time.

An immediate uproar ensued, but after a month of pushback, the political scion said the plans were still on. 

Now, more than a year later, Kennedy told The Guardian he hasn't heard from the White House in six months. He said there's been "zero progress" and that the administration has cut off communications. 

Kennedy and others have pushed for the administration to investigate the disproven theory that vaccines can cause autism. The community who supported Trump because of his tone on vaccines—the president has questioned their safety numerous times—feels betrayed, Kennedy told the newspaper. Founder of World Mercury Project, Kennedy said he believes the president has caved to industry pressure.

Virtual Roundtable

ESMO Post Show: Highlights from the Virtual Conference

Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields. Register today.

Meanwhi, experts are relieved. Last year, several experts said the mere existence of such a commission would stir up more distrust in vaccines at a time when vaccine hesitancy was leading to measles outbreaks around the country.

Dr. Peter Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine, said on Tuesday he "didn't see how it filled a need." 

"I think we have enormous checks and balances in place through the Vaccine Adverse Event Reporting System [and an] incredibly robust system through CDC and ACIP for ensuring vaccine safety that has a track record of catching problems."

The father of a daughter with autism, Dr. Hotez said vaccines are "incredibly safe, incredibly effective and incredibly powerful public health tools" and that it's "discouraging" to see groups keep bringing up the theory that they can cause the developmental disorder. He actually volunteered to serve as a scientific voice on the proposed commission a year ago, he said.

RELATED: Trump's 'not going to back down' from vaccine safety commission, RFK Jr. says after new White House talks 

Despite Trump's public statements questioning vaccine safety, in office he has appointed pro-vaccine leadership to top healthcare posts. Since taking the original Kennedy meeting, Trump has named an FDA commissioner, Scott Gottlieb, who called the theory of a link to autism "thoroughly debunked." 

The administration also appointed Brenda Fitzgerald as CDC director. Even though she recently resigned due to tobacco stock purchases in office, she has unequivocally supported immunizations.

Suggested Articles

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.